Want to join the conversation?
$XYL said that out of the total $725MM in backlog, $525MM is shippable in 2H16, and the remaining $200MM is expected to ship in 2017. 3Q16 shippable backlog is approx. $365MM, which is down 2% organically vs. 3Q15. This represents approx. 40% of the company's expected 3Q16 sales. $XYL expects 2H16 revenue to rise organically in the range of 2-3%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?